Stage I Squamous Cell Carcinoma of the Anus: Is Radiation Therapy Alone Sufficient Treatment?
Autor: | Ansel P. Nalin, A.L.H. Arnett, Ning Jin, Syed Husain, Jose A. Bazan, Dayssy Alexandra Diaz Pardo, Eric D. Miller, Laith Abushahin, Terence M. Williams |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Cancer Research medicine.medical_specialty anal cancer medicine.medical_treatment Population stage I Urology lcsh:RC254-282 Article 03 medical and health sciences 0302 clinical medicine Interquartile range medicine Anal cancer education chemoradiation Chemotherapy education.field_of_study Proportional hazards model business.industry Wide local excision medicine.disease Anus lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens Radiation therapy 030104 developmental biology medicine.anatomical_structure Oncology 030220 oncology & carcinogenesis business |
Zdroj: | Cancers Volume 12 Issue 11 Cancers, Vol 12, Iss 3248, p 3248 (2020) |
ISSN: | 2072-6694 |
DOI: | 10.3390/cancers12113248 |
Popis: | The optimal treatment for stage I squamous cell carcinoma of the anus (SCCA) remains undefined. Recently, wide local excision alone was found to have comparable survival to those treated with chemoradiation (CRT). Given that local excision may be sufficient for the treatment of stage I SCCA, we hypothesized that radiation therapy (RT) alone, compared to CRT would result in equivalent overall survival (OS) in this population. We identified non-surgically treated patients with stage I SCCA from the National Cancer Database from 2004&ndash 2015. We included only patients treated either with CRT (45&ndash 59.4 Gy with chemotherapy initiated within 14 days of RT) or RT alone (45&ndash 59.4 Gy with no chemotherapy). The primary endpoint was OS between CRT and RT patients. Propensity-score matched (PSM) analysis was performed to determine the effect of concurrent chemotherapy on OS using a Cox proportional hazards model with robust standard error to account for clustering in matched pairs. We identified 3552 stage I patients treated with CRT and 287 treated with RT. Compared to patients treated with CRT, those that received RT were more likely to be &ge 70 years old (33.1% vs. 19.7%, p < 0.001) and less likely to be female (63.1% vs. 71.0%, p < 0.001). The proportion of patients with a Charlson-Deyo score of 0 was similar in both groups (80.8% RT vs. 82.7% CRT, p = 0.164). The PSM cohort consisted of 287 pairs of patients with median follow-up 48.3 months (interquartile range, 24.4&ndash 85.1 months) and 151 deaths (86 RT, 65 CRT). CRT was associated with a 31% reduction in the risk of death (HR = 0.69, 95% CI 0.50&ndash 0.95, p = 0.023). We found that CRT was associated with improved OS, compared to RT alone, in patients with non-surgically treated stage I SCCA. These data suggest that de-intensification of therapy in stage I SCCA must be used with caution. However, given the retrospective nature of the data, prospective trials are required. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |